| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5503845 | Parkinsonism & Related Disorders | 2017 | 8 Pages |
Abstract
As far as the authors are aware of, our paper is the first to evaluate the impact of LCIG on dyskinesia by the means of UDysRS. Changes in MDS-UPDRS and UDysRS confirm that LCIG treatment can efficiently improve experiences of daily living in advanced PD.
Keywords
MoCAPDSS-2HRQOLPEG-JHYSPGI-SMADRSMDS-UPDRSDDSLCIGIQRESSNMSSImpulse control disordersMontreal Cognitive Assessmentstandard deviationParkinson's diseaseICDDuodopadyskinesiaLEDDopamine dysregulation syndromeadverse eventinterquartile rangeDisabilityEpworth sleepiness scaleMontgomery-asberg depression rating scaleNon-motor symptoms scaleLevodopa/carbidopa intestinal gelHealth-related quality of life
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Annamária Juhász, Zsuzsanna Aschermann, Péter Ács, József Janszky, Márton Kovács, Attila Makkos, Márk Harmat, Dalma Tényi, Kázmér Karádi, Sámuel Komoly, Annamária Takáts, Adrián Tóth, Helga Nagy, Péter Klivényi, György Dibó,